Candesartan ameliorates arsenic-induced hypertensive vascular remodeling by regularizing angiotensin II and TGF-beta signaling in rats
Highlights • Examined whether candesartan can ameliorate arsenic-induced vascular disorders. • Arsenic caused systemic hypertension & also enhanced AngII-induced blood pressure. • Arsenic elevated AngII & TGF-β levels; up-regulated aortic AT1 & TβRII receptors. • Also increased transduce...
Gespeichert in:
Veröffentlicht in: | Toxicology (Amsterdam) 2016-12, Vol.374, p.29-41 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Highlights • Examined whether candesartan can ameliorate arsenic-induced vascular disorders. • Arsenic caused systemic hypertension & also enhanced AngII-induced blood pressure. • Arsenic elevated AngII & TGF-β levels; up-regulated aortic AT1 & TβRII receptors. • Also increased transducers of MAPK & TGF-β pathways, aortic collagen & thickness. • Candesartan reduced arsenic-induced functional, biochemical & structural changes. |
---|---|
ISSN: | 0300-483X 1879-3185 |
DOI: | 10.1016/j.tox.2016.11.015 |